Gerrit Meijer
Cancer is caused by DNA mutations. There are an increasing number of drugs available that act on specific errors in the DNA of an individual patient’s tumor. A drug that doesn’t fit, like a key in a lock, will not work, while the risk of side effects remains.
Back to newsMore news
Complete DNA analysis for young adults with cancer
KWF finances the expansion of the infrastructure for cancer research in young adults with almost 4.5 million euros. These are …
United in Unique – every individual story is unique
On World Cancer Day, attention is drawn worldwide to the impact of this disease This year’s theme, United in Unique, highlights the fact …
Clinical Cancer Genomics 2025: a cheerful boost for this rapidly emerging field
The Clinical Cancer Genomics Conference 2025 took place on 20–21 March 2025 in Amsterdam. The event website ccg2025.eu has been retired, but …
More and more cancer drugs are only suitable for a small group of patients. However, we are often not capable to find these patients. That is why every patient with metastatic cancer should be genetically screened before starting treatment.